Table 1.
CBT | IGBT IC | IGBT ICIS | p value | |
---|---|---|---|---|
Median age, year (range) | 68 (28-91) | 50 (28-77) | 57 (37-83) | 0.02 |
N (%) | N (%) | N (%) | ||
Groups | 0.19 | |||
FIGO I | 12 (34) | 5 (16) | 13 (22) | |
FIGO II | 16 (46) | 19 (61) | 26 (43) | |
FIGO III + IV | 7 (20) | 7 (23) | 21 (35) | |
Histology | 0.60 | |||
Squamous cell carcinoma | 31 (89) | 25 (81) | 53 (88) | |
Adenocarcinoma | 4 (11) | 6 (19) | 6 (10) | |
Not specified | 0 (0) | 0 (0) | 1 (2) | |
Nodal involvement | 0.17 | |||
Yes | 10 (29) | 16 (52) | 27 (45) | |
EBRT | < 0.001 | |||
3D CRT (45 Gy) | 35 (100) | 19 (61) | 0 (0) | |
IMRT (50 Gy) | 0 (0) | 12 (39) | 60 (100) | |
Concurrent therapy | < 0.001 | |||
Chemotherapy | 20 (57) | 28 (90) | 57 (95) | |
Hyperthermia | 1 (3) | 1 (3) | 1 (2) | |
None | 14 (40) | 2 (7) | 2 (3) |
CBT – conventional brachytherapy, IGBT IC – image-guided brachytherapy intracavitary approach, IGBT ICIS – image-guided brachytherapy intracavitary approach (intentionally) with the use of interstitial needles, 3D CRT – three-dimensional conformal radiation therapy, IMRT – intensity-modulated radiation therapy